Your session is about to expire
← Back to Search
OsciPulse system for Ischemic Stroke
Study Summary
This trial will test a new device to see if it is safe and effective at reducing a protein marker for clotting in stroke patients.
- Ischemic Stroke
- Venous Thrombosis
- Stroke
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this experiment currently recruiting participants?
"Contrary to expectations, the clinical trial detailed on clinicaltrials.gov is not currently recruiting participants. Initially posted in December 2022 and last updated 19th September of the same year, this medical research does not need more volunteers at present; however there are 491 other studies that require enrolment presently."
To what extent might the OsciPulse system be a hazard to patients?
"Our assessment of the safety associated with OsciPulse system yielded a score of 2 due to its Phase 2 status, indicating that there is some evidence for security but no data demonstrating efficacy."
Is participation in this medical trial open to individuals younger than 20 years old?
"To be considered for this trial, applicants must fall within the 18 to 100 years of age range. Moreover, there are 19 trials open to those under 18 and 473 that accept participants over 65."
Is there an opportunity for me to volunteer for this research?
"For this clinical trial, 40 individuals aged 18 to 100 who have experienced a wake-up stroke are being recruited. To qualify for the study, patients must also meet certain additional criteria including having had their last known normal state less than 24 hours ago, an NIH Stroke Score of at least 5 points, be prescribed mechanical therapy for DVT prevention, demonstrate weakness in one or more legs as indicated by 1 point on the NIHSS lower extremity motor scores (6A and 6B)."
Share this study with friends
Copy Link
Messenger